REDFILED Newsdesk - REDFILED (Page 15)

Treasure Global is commissioning a centralized business intelligence platform for its group companies.

TGL

TREASURE GLOBAL Signs $2M Software Deal Payable in Cash or Stock

The Nasdaq-listed Malaysian e-commerce group hired Mestiz Technology to build a centralized Power BI system, with fees settleable in shares at a 5-day VWAP.

Fnac Darty operates around 1,500 stores across 15 European countries.

M&A

FNAC DARTY Bid by EP Group Filed With EU Merger Regulators

EP FR HOLDCO notified Brussels of its €35-per-share tender offer for Fnac Darty, with phase I clearance expected by early November and closing by year-end 2026.

ONCO

ONCONETIX Lends Up to $5M to Realbotix Ahead of Share Exchange

Onconetix will fund Realbotix through a $5 million interest-free grid promissory note that is cancelled at closing of their planned share exchange.

Ondas has agreed to acquire two privately held technology companies in Israel and Poland.

ONDS

ONDAS Acquires Israel's Gate Technologies and Poland's Bron Technologies

Ondas signed a share purchase agreement for 100% of both companies, paying in stock or cash with holdbacks and an earn-out; terms were not disclosed in the exhibit.

PDSB

PDS BIOTECH Raises $11.3M in PIPE Led by Patrick Soon-Shiong

Nant Capital led an initial $11.3 million private placement in PDS Biotech, with up to $11 million more tied to a Phase 3 filing, and two Nant executives joining the board.

Photodynamic therapy is used in dermatology to treat pre-cancerous and cancerous skin lesions.

BFRI

FDA Approves BIOFRONTERA's Ameluz for Superficial Basal Cell Carcinoma

Ameluz with the BF-RhodoLED lamp becomes the first photodynamic therapy cleared in the US to treat a skin cancer, with a launch planned from late 2026.

Cardiff Oncology has amended the license agreement underpinning its lead program.

CRDF

CARDIFF ONCOLOGY Settles Suit With Nerviano, Amends 2017 License

An 8-K discloses a confidential settlement and a rewritten license agreement covering the exclusive worldwide rights Cardiff licensed from Italy's Nerviano Medical Sciences in 2017.

Immersion chairman and chief executive Eric Singer.

IMMR

IMMERSION Swings to $4.9M Profit as Barnes & Noble Education Stake Dilutes

Haptics licensor posts Q1 fiscal 2027 revenue of $294.4 million and declares its sixteenth consecutive quarterly dividend of $0.075 per share.

Sanofi is transferring three manufacturing sites and a portfolio of established medicines to Cheplapharm.

SNY

SANOFI Hands 20 Mature Medicines and Three Plants to Cheplapharm for 26.4% Stake

Sanofi will transfer 20 established medicines, including Lovenox/Clexane outside the US, and three factories to Cheplapharm in exchange for a 26.4% equity stake.

Ameluz gel is used with a red-light lamp to treat skin lesions in a dermatology office.

BFRI

FDA Approves BIOFRONTERA's Ameluz PDT for Superficial Basal Cell Carcinoma

Ameluz combined with the BF-RhodoLED lamp becomes the first photodynamic therapy approved in the US to treat a skin cancer, adding up to 720,000 annual cases to its market.

BTCS

BTCS Takes Imperium DeFi Unit Multi-Chain With Base Integration

BTCS says liquidity-pool assets in its Imperium DeFi arm grew from about $8 million at the end of Q2 to roughly $36 million today.

EOSE

EOS ENERGY Draws $87M From DOE Loan for Second Thorn Hill Line

Eos Energy received an $87 million first advance under the second tranche of its DOE loan, lifting total draws to about $178 million.